Financial intelligence for institutions

Evidence your board and regulator can check.

Noēsis turns core-system data, company filings and market prices into figures and models you can trace to their source, for liquidity and risk teams, research desks and the committees they answer to.

Every number tracedEvery model explainedEvery decision recorded
Noēsis Liquidity · Example

Cumulative gap turns positive after one year; under stress, not until beyond three

◉ Verified
+200−20 ≤7d8d–1m1–3m3–6m6–12m1–3y>3y
InflowsOutflowsCumulative gapStress scenarioLKR bn
◇ Core extract · 31 Oct 2026Scenario S2 · v1.0Illustrative figures
Survival horizon, stress
41 days
● Watch
Liquid assets ÷ requirement
1.28×
▲ Within limit
Principles

Four rules, built into the software

Traceable

Every number links to the document, page and table it came from. No source, no number.

Revenue LKR 48.2bn · AR FY25 p.112

Reviewed

Nothing reaches a committee or board unverified, and its review status is always shown.

◉ Verified

Explained

Every model shows its assumptions, its version and its date, one click from the result.

Base case assumes 6% volume growth

Humble

Models estimate; they do not know. We show ranges, and what would change the view.

Model value LKR 124–176, base 151

Products

One standard of evidence, across treasury, risk and research

Each product does one job well and shares the same foundations: sourced data, versioned models, a review trail and approvals named by role.

NoēsisLiquidityPilots from Q1 2027

Maturity ladders, liquidity ratios, stress tests, early-warning indicators, and board and regulatory reports, built from your core-system extracts.

For: Finance companies, banks

NoēsisResearchPilots from 2027

Company research, valuation models with ranges, and a committee workflow from first draft to approved decision.

For: Brokers, investment managers

NoēsisDataPilots from 2027

Verified financials for every company listed on the Colombo Stock Exchange, with screening, comparisons and exports.

For: Research teams, funds, insurers

NoēsisALMNext

Repricing gaps, and earnings and value sensitivity to interest-rate moves.

For: Finance companies, mid-sized banks

NoēsisFundingPlanned

Funding plans, internal funds transfer pricing and product profitability.

For: Mid-sized banks

NoēsisRecoveryPlanned

Recovery-plan indicator dashboards and a scenario library.

For: Banks, finance companies

Noēsis Liquidity

A complete liquidity risk process, from extract to board pack

Built for finance companies and banks that need to measure, monitor and report liquidity risk with an audit trail, without a global vendor's price or a fragile spreadsheet.

  • Maturity ladders and ratios from your core-system extracts, reconciled and dated.
  • Stress tests with named, versioned scenarios and results shown as ranges.
  • Early-warning indicators against the limits in your board's liquidity policy.
  • Board packs and regulatory returns generated from verified figures only.
  • Approvals by role: risk reviewed, ALCO approved, board approved, all on record.
Regulatory contextThe Central Bank of Sri Lanka's Finance Business Act Directions No. 03 of 2025 require licensed finance companies to put in place a liquidity risk management strategy, policy, governance and a process to measure, monitor and report liquidity risk. Noēsis Liquidity is designed around that process. Pilots start in the first quarter of 2027.
Board liquidity pack · Quarter ended [date] · Example

Early-warning indicators against policy limits

● ALCO approved
Survival horizon, stress scenario S2
41 days
● Watch
Deposit renewal rate, 3 months
86%
▲ Within limit
Top 20 depositors, share of deposits
17%
▲ Within limit
Liquid assets ÷ requirement
1.28×
▲ Within limit
Cumulative gap to 1 month
−LKR 7.0bn
● Watch
Wholesale funding, share
9%
▲ Within limit
◇ Core extract · 31 Oct 2026Policy limits v3 · BoardIllustrative figures
Noēsis Research · Banks · Example

Company A PLC

◐ Analyst reviewed
Price
LKR 132.50
CSE · 13 Nov
Model value · base
LKR 151
Range 124–176 · v1.3
House view · your overlay
Private
Your firm only
124151 base176 Price 132.50

Illustrative figures. A model value is a model estimate, not a recommendation.

Noēsis Research and Noēsis Data

Verified data and models for every listed company

Your analysts should spend their time on judgement, not on retyping annual reports. Noēsis gives your team a clean, consistent engine to build on.

  • Verified financials for every company on the Colombo Stock Exchange, each figure linked to its page in the annual report.
  • Screening and comparisons on one consistent basis, with exports.
  • Valuation models that show their range, assumptions and version.
  • Your private overlay: house views, watchlists and model portfolios stay visible to your firm only.
  • A committee workflow from draft to approved decision, with minutes on record.
Approach

Every figure moves through four states, and you can always see which

The review mark appears on every figure set, model, note and return. Nothing reaches a committee, a board or a regulator without passing through each stage.

○ Draft

Extract

Data arrives from your core systems, filings or exchange feeds, stamped with its source and date.

◉ Verified

Check against source

An independent reading checks each figure against its source. Differences are flagged, never overwritten.

◐ Reviewed

Expert review

An analyst or risk manager reviews the figures and models, and the review is signed and dated.

● Approved

Decision on record

The responsible body (investment committee, ALCO or board) approves, and the decision is recorded with its evidence.

Models and machine learning

The models estimate. Your people decide.

Noēsis uses statistical and machine-learning models where they help, and presents their output as estimates with ranges, never as predictions.

Model output

Labelled, ranged, versioned

  • Always labelled "model estimate" or "model value".
  • Shown with a range, its key assumptions and the scenario or model version.
  • Dated, and linked to the data it used.
  • No accuracy claims without a documented, reviewed back-test.
Your decision

Made by people, kept on record

  • Ratings, targets, limits and approvals are set by your committees, not by a model.
  • Where a decision differs from a model, both are shown and the reason is recorded.
  • Every approval names the body and the date.
Governance and security

Designed to pass your vendor and outsourcing review

Regulated institutions must assess the technology they rely on. Noēsis is built to make that assessment straightforward.

Full audit trail

Every change, review and approval is logged with who, what and when. Nothing is deleted or silently overwritten.

Roles and approvals

Access by role, with separate preparers, reviewers and approvers, so four-eyes control is built in.

Your data stays yours

Client data is kept separate and is never used to serve another client. House views stay in your private overlay.

Licensed sources

Exchange and third-party data are displayed, stored and processed only as each licence permits.

Due-diligence pack

We provide the documentation your outsourcing and technology-risk reviews require, including hosting, security and exit arrangements.

Human sign-off

Nothing reaches a committee, board or regulator without a named person's approval.

Who we work with

Institutions that answer to boards and regulators

Finance companies

Liquidity risk frameworks, stress testing and regulatory reporting.

Liquidity · ALM · Recovery
Banks

Asset-liability management, funding plans and funds transfer pricing.

ALM · Funding · Recovery
Stockbrokers

Research teams that need verified data and models across the market.

Research · Data
Investment managers

Unit trust and portfolio managers, insurers and pension funds.

Research · Data
International funds

Consistent, English-language coverage of Sri Lankan listed companies.

Data · Research
2027 pilot programme

Request a briefing

We are selecting a small number of institutions for three-month pilots starting in the first quarter of 2027.

  1. 01
    Briefing, 30 minutes. How you measure, review and report today, and where the gaps are.
  2. 02
    Data trial. We load a sample of your extracts or coverage and show you the results, sourced and reviewed.
  3. 03
    Three-month pilot. Your team runs Noēsis alongside your current process, with agreed success measures.
Your request is ready to send.

Copy it and email it to .


        
Open in email